Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Key Developments In 2008 For China Pharmaceutical Agents

This article was originally published in PharmAsia News

Executive Summary

With the imminent rollout of China's various medical regulatory policies, drug agents are in for tougher times this year. China Pharmaceutical News has identified several major trends in the industry. 1) Mature brands will comprise the mainstay for local agents in 2008 as the entry barrier is much lower than that for newer drugs. Foreign agents dominate new products due to their market development strengths. 2) With intensifying competition, branded products will become agents' choice as savvy consumers increasingly opt for brand names that promise safety and reliability. 3) Agents are switching from single-product to multiproduct strategy to meet rising operating costs. Selling more products to an existing customer base can grow profit with minimal investment. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066578

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel